These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 29222036)

  • 81. A Quality improvement initiative to reduce central line-associated bloodstream infections in a neonatal intensive care unit in a low-and-middle-income country.
    Al Bizri A; Hanna Wakim R; Obeid A; Daaboul T; Charafeddine L; Mounla N; Nakad P; Yunis K
    BMJ Open Qual; 2023 Jun; 12(2):. PubMed ID: 37308256
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Six-year study on peripheral venous catheter-associated BSI rates in 262 ICUs in eight countries of South-East Asia: International Nosocomial Infection Control Consortium findings.
    Rosenthal VD; Bat-Erdene I; Gupta D; Rajhans P; Myatra SN; Muralidharan S; Mehta Y; Rai V; Hung NV; Luxsuwong M; Tapang ARD; Guo X; Trotter A; Kharbanda M; Rodrigues C; Dwivedy A; Shah S; Poojary A; Todi SK; Chabukswar S; Bhattacharyya M; Ramachandran B; Ramakrishnan N; Purkayasta SK; Sakle AS; Kumar S; Warrier AR; Kavathekar MS; Sahu S; Mubarak A; Modi N; Jaggi N; Gita N; Mishra SB; Sahu S; Jawadwala B; Zala D; Zompa T; Mathur P; Nirkhiwale S; Vadi S; Singh S; Agarwal M; Sen N; Karlekar A; Punia DP; Kumar S; Gopinath R; Nair PK; Gan CS; Chakravarthy M; Sandhu K; Kambam C; Mohanty SK; Varaiya A; Pandya N; Subhedar VR; Vanajakshi MR; Singla D; Tuvshinbayar M; Patel M; Ye G; Lum LCS; Zaini RHM; Batkhuu B; Dayapera KM; Nguyet LT; Berba R; Buenaflor MCS; Ng JA; Siriyakorn N; Thu LTA
    J Vasc Access; 2021 Jan; 22(1):34-41. PubMed ID: 32406328
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Implementation of an insertion bundle for preventing central line-associated bloodstream infections in an Intensive Care Unit in Colombia].
    Osorio J; Álvarez D; Pacheco R; Gómez CA; Lozano A
    Rev Chilena Infectol; 2013 Oct; 30(5):465-73. PubMed ID: 24248159
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Dwell time and risk of central-line-associated bloodstream infection in neonates.
    Sanderson E; Yeo KT; Wang AY; Callander I; Bajuk B; Bolisetty S; Lui K;
    J Hosp Infect; 2017 Nov; 97(3):267-274. PubMed ID: 28651859
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Implementation of central venous catheter bundle in an intensive care unit in Kuwait: Effect on central line-associated bloodstream infections.
    Salama MF; Jamal W; Al Mousa H; Rotimi V
    J Infect Public Health; 2016; 9(1):34-41. PubMed ID: 26138518
    [TBL] [Abstract][Full Text] [Related]  

  • 86. SLUG Bug: Quality Improvement With Orchestrated Testing Leads to NICU CLABSI Reduction.
    Piazza AJ; Brozanski B; Provost L; Grover TR; Chuo J; Smith JR; Mingrone T; Moran S; Morelli L; Zaniletti I; Pallotto EK
    Pediatrics; 2016 Jan; 137(1):. PubMed ID: 26702032
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Eliminating central line-associated bloodstream infections: a national patient safety imperative.
    Berenholtz SM; Lubomski LH; Weeks K; Goeschel CA; Marsteller JA; Pham JC; Sawyer MD; Thompson DA; Winters BD; Cosgrove SE; Yang T; Louis TA; Meyer Lucas B; George CT; Watson SR; Albert-Lesher MI; St Andre JR; Combes JR; Bohr D; Hines SC; Battles JB; Pronovost PJ;
    Infect Control Hosp Epidemiol; 2014 Jan; 35(1):56-62. PubMed ID: 24334799
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Impact of intensified prevention measures on rates of hospital-acquired bloodstream infection in medical-surgical intensive care units, Israel, 2011 to 2019.
    Ben-David D; Vaturi A; Wulffhart L; Temkin E; Solter E; Carmeli Y; Schwaber MJ; ;
    Euro Surveill; 2023 Jun; 28(25):. PubMed ID: 37347415
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Prospective observational study on central line-associated bloodstream infections and central venous catheter occlusions using a negative displacement connector with an alcohol disinfecting cap.
    Patel PA; Boehm S; Zhou Y; Zhu C; Peterson KE; Grayes A; Peterson LR
    Am J Infect Control; 2017 Feb; 45(2):115-120. PubMed ID: 27499191
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Assessment of the quality of publicly reported central line-associated bloodstream infection data in Colorado, 2010.
    Rich KL; Reese SM; Bol KA; Gilmartin HM; Janosz T
    Am J Infect Control; 2013 Oct; 41(10):874-9. PubMed ID: 23498552
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Rates of central line-associated bloodstream infection in tertiary care hospitals in 3 Arabian gulf countries: 6-year surveillance study.
    Balkhy HH; El-Saed A; Al-Abri SS; Alsalman J; Alansari H; Al Maskari Z; El Gammal A; Al Nasser W; AlJardani A; Althaqafi A
    Am J Infect Control; 2017 May; 45(5):e49-e51. PubMed ID: 28318648
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Neonatal sepsis: progress towards improved outcomes.
    Shane AL; Stoll BJ
    J Infect; 2014 Jan; 68 Suppl 1():S24-32. PubMed ID: 24140138
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Bundle approach used to achieve zero central line-associated bloodstream infections in an adult coronary intensive care unit.
    Gupta P; Thomas M; Patel A; George R; Mathews L; Alex S; John S; Simbulan C; Garcia ML; Al-Balushi S; El Hassan M
    BMJ Open Qual; 2021 Feb; 10(1):. PubMed ID: 33597274
    [TBL] [Abstract][Full Text] [Related]  

  • 94. A clinical practical approach to the surveillance definition of central line-associated bloodstream infection in cancer patients with mucosal barrier injury.
    Chaftari AM; Jordan M; Hachem R; Al Hamal Z; Jiang Y; Yousif A; Garoge K; Deshmukh P; Raad I
    Am J Infect Control; 2016 Aug; 44(8):931-4. PubMed ID: 27112370
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Matched case-control analysis of polymicrobial bloodstream infection in a neonatal intensive care unit.
    Bizzarro MJ; Dembry LM; Baltimore RS; Gallagher PG
    Infect Control Hosp Epidemiol; 2008 Oct; 29(10):914-20. PubMed ID: 18808341
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Nosocomial bloodstream infection in a neonatal intensive care unit of a medical center: a three-year review.
    Tseng YC; Chiu YC; Wang JH; Lin HC; Lin HC; Su BH; Chiu HH
    J Microbiol Immunol Infect; 2002 Sep; 35(3):168-72. PubMed ID: 12380789
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Evaluating the impact of mandatory public reporting on participation and performance in a program to reduce central line-associated bloodstream infections: evidence from a national patient safety collaborative.
    Marsteller JA; Hsu YJ; Weeks K
    Am J Infect Control; 2014 Oct; 42(10 Suppl):S209-15. PubMed ID: 25239712
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Impact of a Central Line Infection Prevention Bundle in Newborn Infants.
    McMullan R; Gordon A
    Infect Control Hosp Epidemiol; 2016 Sep; 37(9):1029-36. PubMed ID: 27289400
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Device-associated infection rates in 398 intensive care units in Shanghai, China: International Nosocomial Infection Control Consortium (INICC) findings.
    Tao L; Hu B; Rosenthal VD; Gao X; He L
    Int J Infect Dis; 2011 Nov; 15(11):e774-80. PubMed ID: 21846591
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Controlling catheter-related bloodstream infections through a multi-centre educational programme for intensive care units.
    Musu M; Finco G; Mura P; Landoni G; Piazza MF; Messina M; Tidore M; Mucci M; Campagna M; Galletta M
    J Hosp Infect; 2017 Nov; 97(3):275-281. PubMed ID: 28823548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.